Our top pick for
Itron, Inc is a scientific & technical instruments business based in the US. Itron shares (ITRI) are listed on the NASDAQ and all prices are listed in US Dollars. Itron employs 6,153 staff and has a trailing 12-month revenue of around USD$2.2 billion.
|52-week range||USD$40.48 - USD$120.8|
|50-day moving average||USD$100.8224|
|200-day moving average||USD$79.9588|
|Wall St. target price||USD$122.44|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.485|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Itron stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Itron's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Itron's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, Itron shares trade at around 47x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Itron's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.9854. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Itron's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Itron's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$180.8 million.
The EBITDA is a measure of a Itron's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$2.2 billion|
|Operating margin TTM||3.84%|
|Gross profit TTM||USD$602.2 million|
|Return on assets TTM||1.96%|
|Return on equity TTM||-6.93%|
|Market capitalisation||USD$4.9 billion|
TTM: trailing 12 months
There are currently 882,619 Itron shares held short by investors – that's known as Itron's "short interest". This figure is 26.1% up from 700,028 last month.
There are a few different ways that this level of interest in shorting Itron shares can be evaluated.
Itron's "short interest ratio" (SIR) is the quantity of Itron shares currently shorted divided by the average quantity of Itron shares traded daily (recently around 336877.48091603). Itron's SIR currently stands at 2.62. In other words for every 100,000 Itron shares traded daily on the market, roughly 2620 shares are currently held short.
However Itron's short interest can also be evaluated against the total number of Itron shares, or, against the total number of tradable Itron shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Itron's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Itron shares in existence, roughly 20 shares are currently held short) or 0.0253% of the tradable shares (for every 100,000 tradable Itron shares, roughly 25 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Itron.
Find out more about how you can short Itron stock.
We're not expecting Itron to pay a dividend over the next 12 months.
Over the last 12 months, Itron's shares have ranged in value from as little as $40.48 up to $120.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Itron's is 1.207. This would suggest that Itron's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Itron, Inc., a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing. The Networked Solutions segment provides a combination of communicating devices, such as smart meters, modules, endpoints, and sensors; network infrastructure; and associated application software for acquiring and transporting application-specific data. The Outcomes segment offers enhanced software and services for managing, organizing, analyzing, and interpreting data to enhance decision making, maximize operational profitability, drive resource efficiency, and deliver results for consumers, utilities, and smart cities. In addition, it offers software implementation, project management, installation, consulting, and post-sale maintenance support services, as well as cloud and software-as-a-service; and extended or customer-specific warranties. It offers its products and services under the Itron brand. The company markets its products directly through its sales force, as well as through indirect sales force consisting of distributors, sales representatives, partners, and meter manufacturer representatives to utilities and municipalities. Itron, Inc. was founded in 1977 and is headquartered in Liberty Lake, Washington.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.